{
    "clinical_study": {
        "@rank": "3089", 
        "arm_group": [
            {
                "arm_group_label": "Human Insulin", 
                "arm_group_type": "Active Comparator", 
                "description": "Nasal spray"
            }, 
            {
                "arm_group_label": "Placebo solution", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Nasal spray"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to investigate whether insulin sensitivity and insulin\n      resistance of the human brain is comparable in all insulin sensitive parts of the brain and\n      whether correlates to other phenotypic information (i.e. whole body insulin sensitivity,\n      BMI, age) of the study participants."
        }, 
        "brief_title": "Insulin Sensitivity of the Human CNS System: fMRI Study With Intranasal Insulin Application", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "condition": [
            "Obesity", 
            "Diabetes"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Obesity", 
                "Insulin Resistance"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Normal routine blood works\n\n          -  for women: negative pregnancy test\n\n          -  healthy\n\n        Exclusion Criteria:\n\n          -  Type 2 diabetes\n\n          -  pregnancy\n\n          -  acute or chronic diseases\n\n          -  Pacemakers\n\n          -  Artificial heart valves\n\n          -  Metal prostheses\n\n          -  Implanted magnetic metal parts (screws, ...)\n\n          -  Metal fragments\n\n          -  Braces\n\n          -  insulin pumps\n\n          -  Tattoos\n\n          -  claustrophobia\n\n          -  reduced temperature sensation and / or increased sensitivity to warming of the body\n\n          -  Ear disease or an increased sensitivity to loud noises"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "48", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01797601", 
            "org_study_id": "Eudra-CT: 2006-002244-29", 
            "secondary_id": "17/2008AMG1"
        }, 
        "intervention": {
            "arm_group_label": "Human Insulin", 
            "description": "160 U of insulin", 
            "intervention_name": "Human Insulin", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Insulin"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 6, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tuebingen", 
                    "country": "Germany", 
                    "zip": "72074"
                }, 
                "name": "University of Tuebingen"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Insulinsensitivit\u00e4t Des Menschlichen Zentralnervensystems: Kernspintomographische Untersuchung Mit Intranasaler Gabe Von Insulin", 
        "overall_official": {
            "affiliation": "University of Tuebingen, Germany", 
            "last_name": "Andreas Fritsche, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Insulin effect on regional brain activity assessed by fMRI", 
            "safety_issue": "No", 
            "time_frame": "Change from Baseline to 15 minutes and 60 minutes post spray application"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01797601"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital Tuebingen", 
            "investigator_full_name": "andreas fritsche", 
            "investigator_title": "Prof. Andreas Fritsche", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University Hospital Tuebingen", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital Tuebingen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}